---
input_text: "Recent advances in primary ciliary dyskinesia. Primary ciliary dyskinesia
  (PCD) is a genetic disease inherited in an autosomal recessive manner. The prevalence
  of PCD is estimated to be 1 in 20,000 live births. Congenital abnormality of the
  primary cilia results in situs inversus in 50% of patients. Decreased function of
  motile cilia causes chronic rhinosinusitis, otitis media with effusion, bronchiectasis
  and infertility. Cases with situs inversus are considered to show \"Kartagener's
  syndrome\", and diagnosis is not difficult. However, in cases without situs inversus,
  the diagnosis is much more troublesome. PCD without situs inversus is thus probably
  underdiagnosed. Prolonged chronic cough represents an important symptom that is
  seen in most patients. The diagnosis of PCD requires the presence of the characteristic
  clinical phenotypes and either: (1) specific ciliary ultrastructural defects identified
  by transmission electron microscopy in biopsy samples of respiratory epithelium;
  or (2) identification of mutation in one of the genes known to be associated with
  PCD. Nasal nitric oxide concentration is extremely low in PCD, and this could be
  useful for screening of the disease. At present, no fundamental therapies are available
  for PCD. Diagnosis in the early stages is important to prevent progression of bronchiectasis
  and deterioration of lung function by guidance for daily life, immunization, cessation
  of smoking and prompt therapy at the time of respiratory tract infection. Since
  PCD is inherited in an autosomal-recessive manner, genetic counseling is necessary
  after definite diagnosis. "
raw_completion_output: |-
  primary_disease: Primary ciliary dyskinesia (PCD)

  medical_actions: guidance for daily life; immunization; cessation of smoking; prompt therapy at the time of respiratory tract infection; genetic counseling; screening using nasal nitric oxide concentration; transmission electron microscopy; identification of mutation

  symptoms: situs inversus; chronic rhinosinusitis; otitis media with effusion; bronchiectasis; infertility; prolonged chronic cough

  chemicals: 

  action_annotation_relationships: guidance for daily life PREVENTS progression of bronchiectasis IN Primary ciliary dyskinesia (PCD); immunization PREVENTS deterioration of lung function IN Primary ciliary dyskinesia (PCD); cessation of smoking PREVENTS deterioration of lung function IN Primary ciliary dyskinesia (PCD); prompt therapy at the time of respiratory tract infection PREVENTS progression of bronchiectasis IN Primary ciliary dyskinesia (PCD); genetic counseling PREVENTS transmission IN Primary ciliary dyskinesia (PCD); screening using nasal nitric oxide concentration IDENTIFIES Primary ciliary dyskinesia (PCD) IN Primary ciliary dyskinesia (PCD); transmission electron microscopy IDENTIFIES ciliary ultrastructural defects IN Primary ciliary dyskinesia (PCD); identification of mutation IDENTIFIES Primary ciliary dyskinesia (PCD) IN Primary ciliary dyskinesia (PCD)
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  identification of mutation IDENTIFIES Primary ciliary dyskinesia (PCD) IN Primary ciliary dyskinesia (PCD)

  ===

extracted_object:
  primary_disease: MONDO:0008932
  medical_actions:
    - guidance for daily life
    - MAXO:0000118
    - cessation of smoking
    - prompt therapy at the time of respiratory tract infection
    - MAXO:0000079
    - screening using nasal nitric oxide concentration
    - transmission electron microscopy
    - identification of mutation
  symptoms:
    - HP:0001696
    - HP:0011109
    - HP:0031353
    - HP:0002110
    - HP:0000789
    - prolonged chronic cough
  action_annotation_relationships:
    - subject: guidance for daily life
      predicate: PREVENTS
      object: progression of bronchiectasis
      qualifier: MONDO:0008932
    - subject: MAXO:0000118
      predicate: PREVENTS
      object: deterioration of lung function
      qualifier: MONDO:0008932
    - subject: cessation of smoking
      predicate: PREVENTS
      object: deterioration of lung function
      qualifier: MONDO:0008932
    - subject: prompt therapy
      predicate: PREVENTS
      object: progression of bronchiectasis
      qualifier: MONDO:0008932
      subject_qualifier: at the time of respiratory tract infection
    - subject: MAXO:0000079
      predicate: PREVENTS
      object: transmission
      qualifier: MONDO:0008932
    - subject: <screening>
      predicate: <IDENTIFIES>
      object: HP:0012265
      qualifier: MONDO:0008932
      subject_qualifier: <using>
      subject_extension: <nasal nitric oxide concentration>
    - subject: <transmission electron microscopy>
      predicate: <IDENTIFIES>
      object: <ciliary ultrastructural defects>
      qualifier: <Primary ciliary dyskinesia>
      subject_qualifier: <>
      object_qualifier: <>
      subject_extension: <transmission electron microscopy>
      object_extension: <ciliary ultrastructural defects>
    - subject: identification of mutation
      predicate: IDENTIFIES
      object: HP:0012265
      qualifier: MONDO:0008932
named_entities:
  - id: MONDO:0008932
    label: Primary ciliary dyskinesia (PCD)
  - id: HP:0034315
    label: Chronic cough
  - id: HP:0002643
    label: Neonatal respiratory distress
  - id: MAXO:0000506
    label: non-invasive ventilation (NIV)
  - id: HP:0003251
    label: Male infertility
  - id: HP:0001696
    label: Situs inversus
  - id: MONDO:0004247
    label: Peptic Ulcer Disease (PUD)
  - id: MAXO:0001193
    label: Upper gastrointestinal endoscopy
  - id: HP:0002239
    label: Gastrointestinal hemorrhage
  - id: CHEBI:18361
    label: Proton pump inhibitor (PPI)
  - id: CHEBI:49200
    label: Proton pump inhibitor
  - id: HP:0002044
    label: Zollinger-Ellison syndrome
  - id: MONDO:0016575
    label: Primary Ciliary Dyskinesia
  - id: MONDO:0009061
    label: Cystic Fibrosis
  - id: CHEBI:33281
    label: antibiotics
  - id: HP:0012262
    label: Abnormal ciliary motility
  - id: CHEBI:41774
    label: Tamoxifen
  - id: MAXO:0001298
    label: therapy
  - id: HP:0100750
    label: atelectasis
  - id: HP:0002878
    label: respiratory failure
  - id: HP:0011962
    label: Obstructive azoospermia
  - id: HP:0004395
    label: malnutrition
  - id: MONDO:0100096
    label: COVID-19 infection
  - id: MONDO:0008377
    label: recurrent pneumonia (RP)
  - id: MONDO:0005936
    label: recurrent pneumonia
  - id: HP:0000246
    label: Sinusitis
  - id: HP:0002110
    label: Bronchiectasis
  - id: MONDO:0018597
    label: Plastic bronchitis
  - id: CHEBI:29864
    label: Mannitol
  - id: CHEBI:28864
    label: Tobramycin
  - id: CHEBI:161680
    label: Aztreonam
  - id: CHEBI:37943
    label: Colistin
  - id: CHEBI:2637
    label: Amikacin
  - id: CHEBI:77034
    label: mucolytics
  - id: MONDO:0018677
    label: heterotaxy
  - id: MAXO:0025001
    label: cardiac surgery
  - id: MAXO:0000503
    label: mechanical ventilation
  - id: MAXO:0000504
    label: tracheostomies
  - id: HP:0001627
    label: congenital heart disease
  - id: HP:0001708
    label: right-sided heart failure
  - id: MAXO:0000003
    label: Diagnostic testing
  - id: MAXO:0000011
    label: physiotherapy
  - id: HP:0000388
    label: otitis media
  - id: HP:0031245
    label: wet cough
  - id: MAXO:0000516
    label: chest physiotherapy
  - id: HP:0011109
    label: chronic sinusitis
  - id: HP:0001651
    label: dextrocardia
  - id: MAXO:0001001
    label: Gene therapy
  - id: HP:0002088
    label: Lung disease
  - id: MONDO:0018982
    label: Nasopharyngeal carcinoma (NPC)
  - id: MONDO:0015459
    label: Nasopharyngeal carcinoma
  - id: MAXO:0000118
    label: immunization
  - id: MAXO:0000079
    label: genetic counseling
  - id: HP:0031353
    label: otitis media with effusion
  - id: HP:0000789
    label: infertility
  - id: HP:0012265
    label: <Primary ciliary dyskinesia (PCD)>
